Swiss Go Trial Group Report issue

Academic/Hospital Phase 3

Organization Overview

First Clinical Trial
2020
NCT04111978
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2020

Timeline

NOW
  • Now

Alternative names

Swiss Go Trial Group